Liver test abnormalities predict complicated disease behaviour in patients with newly diagnosed Crohn’s disease

por Barendregt, Jessika, de Jong, Myrthe, Haans, Jeoffrey J., van Hoek, Bart, Hardwick, James, Veenendaal, Roeland, van der Meulen, Andrea, Srivastava, Nidhi, Stuyt, Rogier, Maljaars, Jeroen
Publicado 2016

Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial

por Janssen, Laura, Romberg-Camps, Mariëlle, van Bodegraven, Ad, Haans, Jeoffrey, Aquarius, Michèl, Boekema, Paul, Munnecom, Tamara, Brandts, Lloyd, Joore, Manuela, Masclee, Adrian, Jonkers, D, Pierik, M
Publicado 2021

The reproducibility of skeletal muscle signal intensity on routine magnetic resonance imaging in Crohn's disease

por Spooren, Corinne E.G.M., Lodewick, Toine M., Beelen, Evelien M.J., van Dijk, David P.J., Bours, Martijn J.L., Haans, Jeoffrey J., Masclee, Ad A.M., Pierik, Marie J., Bakers, Frans C.H., Jonkers, Daisy M.A.E.
Publicado 2020

Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre...

por Asscher, Vera E. R., Biemans, Vince B. C., Pierik, Marieke J., Dijkstra, Gerard, Löwenberg, Mark, van der Marel, Sander, de Boer, Nanne K. H., Bodelier, Alexander G. L., Jansen, Jeroen M., West, Rachel L., Haans, Jeoffrey J. L., van Dop, Willemijn A., Weersma, Rinse K., Hoentjen, Frank, Maljaars, P. W. Jeroen
Publicado 2020

Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study

por Biemans, Vince B C, van der Meulen - de Jong, Andrea E, van der Woude, Christine J, Löwenberg, Mark, Dijkstra, Gerard, Oldenburg, Bas, de Boer, Nanne K H, van der Marel, Sander, Bodelier, Alexander G L, Jansen, Jeroen M, Haans, Jeoffrey J L, Theeuwen, Rosaline, de Jong, Dirk, Pierik, Marie J, Hoentjen, Frank
Publicado 2020

Vedolizumab for Inflammatory Bowel Disease: Two‐Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registr...

por Biemans, Vince B.C., van der Woude, C. Janneke, Dijkstra, Gerard, van der Meulen‐de Jong, Andrea E., Oldenburg, Bas, de Boer, Nanne K., Löwenberg, Mark, Srivastava, Nidhi, Bodelier, Alexander G.L., West, Rachel L., Jansen, Jeroen M., de Vries, Annemarie C., Haans, Jeoffrey J.L., de Jong, Dirk J., Pierik, Marie J., Hoentjen, Frank
Publicado 2019

Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatment

por Biemans, Vince B. C., van der Woude, C. Janneke, Dijkstra, Gerard, van der Meulen‐de Jong, Andrea E., Löwenberg, Mark, de Boer, Nanne K., Oldenburg, Bas, Srivastava, Nidhi, Jansen, Jeroen M., Bodelier, Alexander G. L., West, Rachel L., de Vries, Annemarie C., Haans, Jeoffrey J. L., de Jong, Dirk, Hoentjen, Frank, Pierik, Marieke J.
Publicado 2020